Yu‐Li Chen
Impact in
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 26
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Wen‐Fang Cheng (52 shared papers)Chi‐An Chen (34 shared papers)Ying‐Cheng Chiang (27 shared papers)Han-Wei Lin (16 shared papers)Samuel D. Wright (2 shared papers)John G. Menke (2 shared papers)Gaochao Zhou (2 shared papers)Karen L. MacNaul (2 shared papers)
- Journals
- Cancer Letters (5 papers)Cancer Medicine (4 papers)Frontiers in Pharmacology (4 papers)International Journal of Environmental Research and Public Health (3 papers)International Journal of Gynecology & Obstetrics (3 papers)
- Partner nations
- TaiwanChinaSouth Korea
In The Last Decade
Yu‐Li Chen
105 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 128
- Reproductive Medicine 303
- Oncology 889
- Immunology 565
- Obstetrics and Gynecology 206
- Cancer Research 395
Countries citing papers authored by Yu‐Li Chen
This map shows the geographic impact of Yu‐Li Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Li Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Li Chen more than expected).
Fields of papers citing papers by Yu‐Li Chen
This network shows the impact of papers produced by Yu‐Li Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Li Chen. The network helps show where Yu‐Li Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Li Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 450 | |
| 2 | 2011 | 128 | |
| 3 | 2017 | 127 | |
| 4 | 2011 | 116 | |
| 5 | 2001 | 85 | |
| 6 | 2010 | 82 | |
| 7 | 2019 | 75 | |
| 8 | 2012 | 63 | |
| 9 | 2014 | 55 | |
| 10 | 2019 | 50 | |
| 11 | 2012 | 49 | |
| 12 | 2020 | 44 | |
| 13 | 2019 | 43 | |
| 14 | 2008 | 42 | |
| 15 | 2015 | 41 | |
| 16 | 2018 | 41 | |
| 17 | 2020 | 39 | |
| 18 | 2021 | 39 | |
| 19 | 2017 | 39 | |
| 20 | 2019 | 39 |
About Yu‐Li Chen
Yu‐Li Chen is a scholar working on Molecular Biology, Oncology, Reproductive Medicine, Immunology and Obstetrics and Gynecology, having authored 115 papers that have together received 2.6k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (19 papers), Ovarian cancer diagnosis and treatment (18 papers), Immunotherapy and Immune Responses (11 papers), Uterine Myomas and Treatments (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immune Cell Function and Interaction (10 papers), Endometriosis Research and Treatment (9 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Reproductive Medicine (303 citations), Oncology (889 citations), Immunology (565 citations), Obstetrics and Gynecology (206 citations) and Cancer Research (395 citations). Yu‐Li Chen has collaborated with scholars based in Taiwan, China and South Korea. Frequent co-authors include Wen‐Fang Cheng, Chi‐An Chen, Ying‐Cheng Chiang, Han-Wei Lin, Samuel D. Wright, John G. Menke, Gaochao Zhou, Karen L. MacNaul, Carl P. Sparrow and Ming‐Cheng Chang. Their work appears in journals such as Cancer Letters, Cancer Medicine, Frontiers in Pharmacology, International Journal of Environmental Research and Public Health and International Journal of Gynecology & Obstetrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.